Clinical Trial: Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Ischemic Stroke, Acute
Study Type: INTERVENTIONAL
Official Title: Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5 Improving Neurological Functional Outcomes in Basilar Artery Occlusion With Tenecteplase in Extended Time Window: Multicent
Brief Summary:
The trial is a multicentre, prospective, open-label, blinded endpoint (PROBE), phase 3, randomized controlled design.Patients with acute ischemic stroke due to basilar artery occlusion presenting within 24 hours will be randomized 1:1 to intravenous tenecteplase (0.25mg/kg, maximum 25mg) ± thrombectomy or 'best practice'which may be alteplase (0.9mg/kg) within 4.5 hours from stroke onset or standard care (no lysis) ± thrombectomy at treating clinician's discretion.
Read more